Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 344

1.

Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings.

Trickey A, van Sighem A, Stover J, Abgrall S, Grabar S, Bonnet F, Berenguer J, Wyen C, Casabona J, d'Arminio Monforte A, Cavassini M, Del Amo J, Zangerle R, Gill MJ, Obel N, Sterne JAC, May MT.

AIDS. 2019 Dec 15;33 Suppl 3:S271-S281. doi: 10.1097/QAD.0000000000002387.

PMID:
31800404
2.

Parameter estimates for trends and patterns of excess mortality among persons on ART in high-income european settings.

Trickey A, van Sighem A, Stover J, Abgrall S, Grabar S, Bonnet F, Berenguer J, Wyen C, Casabona J, Monforte AD'A, Cavassini M, Del Amo J, Zangerle R, Gill MJ, Obel N, Sterne JAC, May MT.

AIDS. 2019 Nov 19. doi: 10.1097/QAD.0000000000002387. [Epub ahead of print]

PMID:
31764067
3.

Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients.

Olearo F, Nguyen H, Bonnet F, Yerly S, Wandeler G, Stoeckle M, Cavassini M, Scherrer A, Costagiola D, Schmid P, Günthard HF, Bernasconi E, Boeni J, D'arminio Monforte A, Zazzi M, Rossetti B, Neau D, Bellecave P, Rijnders B, Reiss P, Wit F, Kouyos R, Calmy A.

Open Forum Infect Dis. 2019 Jul 12;6(10):ofz330. doi: 10.1093/ofid/ofz330. eCollection 2019 Oct.

4.

Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort.

Surial B, Cavassini M, Calmy A, Fehr J, Stöckle M, Bernasconi E, Roth B, Fux CA, Kovari H, Furrer H, Rauch A, Wandeler G; Swiss HIV Cohort Study.

BMC Infect Dis. 2019 Oct 10;19(1):834. doi: 10.1186/s12879-019-4454-9.

5.

The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.

Métral M, Darling K, Locatelli I, Nadin I, Santos G, Brugger P, Kovari H, Cusini A, Gutbrod K, Tarr PE, Calmy A, Lecompte TD, Assal F, Monsch A, Kunze U, Stoeckle M, Schwind M, Schmid P, Pignatti R, Di Benedetto C, Du Pasquier R, Cavassini M; NAMACO study group; Swiss HIV Cohort Study.

HIV Med. 2019 Oct 7. doi: 10.1111/hiv.12795. [Epub ahead of print]

6.

Imaging patterns of Pneumocystis jirovecii pneumonia in HIV-positive and renal transplant patients - a multicentre study.

Christe A, Walti L, Charimo J, Rauch A, Furrer H, Meyer A, Huynh-Do U, Heverhagen JT, Mueller NJ, Cavassini M, Mombelli M, van Delden C, Frauenfelder T, Montet X, Beigelman-Aubry C, Arampatzis S, Ebner L.

Swiss Med Wkly. 2019 Oct 3;149:w20130. doi: 10.4414/smw.2019.20130. eCollection 2019 Sep 23.

7.

Self-reported neurocognitive impairment in people living with HIV: Characterizing clusters of patients with similar changes in self-reported neurocognitive impairment 2013-2017 in the Swiss HIV Cohort Study.

Kusejko K, Salazar-Vizcaya L, Braun DL, Tarr PE, Bernasconi E, Doco-Lecompte T, Cavassini M, Schmid P, Du Pasquier R, Hauser C, Günthard HF, Kouyos RD; Swiss HIV Cohort Study.

Clin Infect Dis. 2019 Sep 3. pii: ciz868. doi: 10.1093/cid/ciz868. [Epub ahead of print]

PMID:
31504323
8.

Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIV.

Courlet P, Stader F, Guidi M, Alves Saldanha S, Stoeckle M, Cavassini M, Battegay M, Buclin T, Decosterd LA, Marzolini C; Swiss HIV Cohort Study.

AIDS. 2020 Jan 1;34(1):103-108. doi: 10.1097/QAD.0000000000002372.

PMID:
31490233
9.

Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017.

Ruffieux Y, Lemsalu L, Aebi-Popp K, Calmy A, Cavassini M, Fux CA, Günthard HF, Marzolini C, Scherrer A, Vernazza P, Keiser O, Egger M; Swiss HIV Cohort Study and the Swiss National Cohort.

J Int AIDS Soc. 2019 Aug;22(8):e25339. doi: 10.1002/jia2.25339.

10.

UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV.

Courlet P, Spaggiari D, Desfontaine V, Cavassini M, Alves Saldanha S, Buclin T, Marzolini C, Csajka C, Decosterd LA.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Sep 1;1125:121733. doi: 10.1016/j.jchromb.2019.121733. Epub 2019 Jul 25.

PMID:
31374423
11.

Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement.

Banga R, Rebecchini C, Procopio FA, Noto A, Munoz O, Ioannidou K, Fenwick C, Ohmiti K, Cavassini M, Corpataux JM, de Leval L, Pantaleo G, Perreau M.

PLoS Pathog. 2019 Jul 22;15(7):e1007918. doi: 10.1371/journal.ppat.1007918. eCollection 2019 Jul.

12.

Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.

Bachmann N, von Siebenthal C, Vongrad V, Turk T, Neumann K, Beerenwinkel N, Bogojeska J, Fellay J, Roth V, Kok YL, Thorball CW, Borghesi A, Parbhoo S, Wieser M, Böni J, Perreau M, Klimkait T, Yerly S, Battegay M, Rauch A, Hoffmann M, Bernasconi E, Cavassini M, Kouyos RD, Günthard HF, Metzner KJ; Swiss HIV Cohort Study.

Nat Commun. 2019 Jul 19;10(1):3193. doi: 10.1038/s41467-019-10884-9.

13.

Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland.

Santos GMA, Locatelli I, Métral M, Calmy A, Lecompte TD, Nadin I, Hauser C, Cusini A, Hasse B, Kovari H, Tarr P, Stoeckle M, Fux C, Di Benedetto C, Schmid P, Darling KEA, Du Pasquier R, Cavassini M; Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) Study Group.

Open Forum Infect Dis. 2019 Jul 8;6(7):ofz277. doi: 10.1093/ofid/ofz277. eCollection 2019 Jul.

14.

IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.

Wójtowicz A, Bibert S, Taffé P, Bernasconi E, Furrer H, Günthard HF, Hoffmann M, Osthoff M, Cavassini M, Bochud PY; Swiss HIV Cohort Study.

AIDS. 2019 Sep 1;33(11):1719-1727. doi: 10.1097/QAD.0000000000002283.

15.

Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment.

Courlet P, Guidi M, Glatard A, Alves Saldanha S, Cavassini M, Buclin T, Marzolini C, Eap CB, Decosterd LA, Csajka C; Swiss HIV Cohort Study.

Br J Clin Pharmacol. 2019 Sep;85(9):2022-2032. doi: 10.1111/bcp.13994. Epub 2019 Jul 7.

PMID:
31144347
16.

Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life setting.

Barcelo C, Aouri M, Courlet P, Guidi M, Braun DL, Günthard HF, Piso RJ, Cavassini M, Buclin T, Decosterd LA, Csajka C; Swiss HIV Cohort Study .

J Antimicrob Chemother. 2019 Sep 1;74(9):2690-2697. doi: 10.1093/jac/dkz217.

PMID:
31119275
17.

HIV Transmission Chains Exhibit Greater HLA-B Homogeneity Than Randomly Expected.

Nguyen H, Thorball CW, Fellay J, Böni J, Yerly S, Perreau M, Klimkait T, Kusejko K, Bachmann N, Chaudron SE, Paioni P, Thurnheer MC, Battegay M, Cavassini M, Vernazza P, Bernasconi E, Günthard HF, Kouyos R; Swiss HIV Cohort Study.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):508-515. doi: 10.1097/QAI.0000000000002077.

PMID:
31107301
18.

Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence.

Courlet P, Decosterd LA, Brown JA, Alves Saldanha S, Marzolini C, Cavassini M, Stoeckle M, Csajka C, Labhardt ND, Calmy A; Swiss HIV Cohort Study .

J Antimicrob Chemother. 2019 Aug 1;74(8):2468-2470. doi: 10.1093/jac/dkz181. No abstract available.

PMID:
31065722
19.

The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study.

Young J, Scherrer AU, Calmy A, Tarr PE, Bernasconi E, Cavassini M, Hachfeld A, Vernazza P, Günthard HF, Bucher HC; Swiss HIV Cohort Study.

Antivir Ther. 2019;24(5):343-353. doi: 10.3851/IMP3310.

PMID:
30985290
20.

Contribution of genetic background and clinical D:A:D risk score to chronic kidney disease in Swiss HIV-positive persons with normal baseline estimated glomerular filtration rate.

Dietrich LG, Barceló C, Thorball CW, Ryom L, Burkhalter F, Hasse B, Furrer H, Weisser M, Steffen A, Bernasconi E, Cavassini M, de Seigneux S, Csajka C, Fellay J, Ledergerber B, Tarr PE; Swiss HIV CohortS Study.

Clin Infect Dis. 2019 Apr 6. pii: ciz280. doi: 10.1093/cid/ciz280. [Epub ahead of print]

PMID:
30953057
21.

Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients.

Abela IA, Scherrer AU, Böni J, Yerly S, Klimkait T, Perreau M, Hirsch HH, Furrer H, Calmy A, Schmid P, Cavassini M, Bernasconi E, Günthard HF; Swiss HIV Cohort Study.

Clin Infect Dis. 2019 Mar 7. pii: ciz178. doi: 10.1093/cid/ciz178. [Epub ahead of print]

PMID:
30843028
22.

A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 With Coinfections, Noncommunicable Diseases, and Opportunistic Diseases.

Kusejko K, Bachmann N, Chaudron SE, Nguyen H, Braun DL, Hampel B, Battegay M, Bernasconi E, Calmy A, Cavassini M, Hoffmann M, Böni J, Yerly S, Klimkait T, Perreau M, Rauch A, Günthard HF, Kouyos RD; Swiss HIV Cohort Study .

J Infect Dis. 2019 Jun 19;220(2):244-253. doi: 10.1093/infdis/jiz093.

PMID:
30835292
23.

Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since Infection.

Carlisle LA, Turk T, Kusejko K, Metzner KJ, Leemann C, Schenkel CD, Bachmann N, Posada S, Beerenwinkel N, Böni J, Yerly S, Klimkait T, Perreau M, Braun DL, Rauch A, Calmy A, Cavassini M, Battegay M, Vernazza P, Bernasconi E, Günthard HF, Kouyos RD; Swiss HIV Cohort Study .

J Infect Dis. 2019 Jun 19;220(2):254-265. doi: 10.1093/infdis/jiz094.

PMID:
30835266
24.

Changing Trends in International Versus Domestic HCV Transmission in HIV-Positive Men Who Have Sex With Men: A Perspective for the Direct-Acting Antiviral Scale-Up Era.

Salazar-Vizcaya L, Kouyos RD, Metzner KJ, Caraballo Cortes K, Böni J, Shah C, Fehr J, Braun DL, Bernasconi E, Mbunkah HA, Hoffmann M, Labhardt N, Cavassini M, Rougemont M, Günthard HF, Keiser O, Rauch A; Swiss HIV Cohort Study .

J Infect Dis. 2019 Jun 5;220(1):91-99. doi: 10.1093/infdis/jiz069.

25.

[Diagnosis, prevention and treatment of HIV : what's new in 2018 ?]

D'Incau S, Viala B, Ciuffi A, Cavassini M, Calmy A.

Rev Med Suisse. 2019 Jan 9;15(N° 632-633):107-112. Review. French.

PMID:
30629381
26.

Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.

Gras L, May M, Ryder LP, Trickey A, Helleberg M, Obel N, Thiebaut R, Guest J, Gill J, Crane H, Dias Lima V, dʼArminio Monforte A, Sterling TR, Miro J, Moreno S, Stephan C, Smith C, Tate J, Shepherd L, Saag M, Rieger A, Gillor D, Cavassini M, Montero M, Ingle SM, Reiss P, Costagliola D, Wit FWNM, Sterne J, de Wolf F, Geskus R; Antiretroviral Therapy Cohort Collaboration (ART-CC).

J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):292-300. doi: 10.1097/QAI.0000000000001913.

27.

Non-targeted HIV testing in the emergency department: not just how but where.

Tan R, Hugli O, Cavassini M, Darling K.

Expert Rev Anti Infect Ther. 2018 Dec;16(12):893-905. doi: 10.1080/14787210.2018.1545575. Epub 2018 Nov 20. Review.

PMID:
30406726
28.

Effect of national HIV testing recommendations and local interventions on HIV testing practices in a Swiss university hospital: a retrospective analysis between 2012 and 2015.

Lazzarino T, Martenet S, Mamin R, Du Pasquier RA, Peters S, Perreau M, Muller O, Hugli O, Cavassini M, Darling KEA.

BMJ Open. 2018 Oct 3;8(10):e021203. doi: 10.1136/bmjopen-2017-021203.

29.

Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study.

Kusejko K, Kadelka C, Marzel A, Battegay M, Bernasconi E, Calmy A, Cavassini M, Hoffmann M, Böni J, Yerly S, Klimkait T, Perreau M, Rauch A, Günthard HF, Kouyos RD; Swiss HIV Cohort Study .

Virus Evol. 2018 Sep 18;4(2):vey024. doi: 10.1093/ve/vey024. eCollection 2018 Jul. Review.

30.

Interferon lambda 3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma.

Bibert S, Wójtowicz A, Taffé P, Tarr PE, Bernasconi E, Furrer H, Günthard HF, Hoffmann M, Kaiser L, Osthoff M, Fellay J, Cavassini M, Bochud PY; Swiss HIV Cohort Study.

AIDS. 2018 Nov 28;32(18):2759-2765. doi: 10.1097/QAD.0000000000002004.

31.

Tracing HIV-1 strains that imprint broadly neutralizing antibody responses.

Kouyos RD, Rusert P, Kadelka C, Huber M, Marzel A, Ebner H, Schanz M, Liechti T, Friedrich N, Braun DL, Scherrer AU, Weber J, Uhr T, Baumann NS, Leemann C, Kuster H, Chave JP, Cavassini M, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Metzner KJ, Günthard HF, Trkola A; Swiss HIV Cohort Study.

Nature. 2018 Sep;561(7723):406-410. doi: 10.1038/s41586-018-0517-0. Epub 2018 Sep 10.

PMID:
30202088
32.

Molecular characterization of Treponema pallidum subsp. pallidum in Switzerland and France with a new multilocus sequence typing scheme.

Grillová L, Bawa T, Mikalová L, Gayet-Ageron A, Nieselt K, Strouhal M, Sednaoui P, Ferry T, Cavassini M, Lautenschlager S, Dutly F, Pla-Díaz M, Krützen M, González-Candelas F, Bagheri HC, Šmajs D, Arora N, Bosshard PP.

PLoS One. 2018 Jul 30;13(7):e0200773. doi: 10.1371/journal.pone.0200773. eCollection 2018.

33.

Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland.

Kusejko K, Marzel A, Hampel B, Bachmann N, Nguyen H, Fehr J, Braun DL, Battegay M, Bernasconi E, Calmy A, Cavassini M, Hoffmann M, Böni J, Yerly S, Klimkait T, Perreau M, Rauch A, Günthard HF, Kouyos RD; Swiss HIV Cohort Study.

HIV Med. 2018 Nov;19(10):688-697. doi: 10.1111/hiv.12660. Epub 2018 Jul 26.

PMID:
30051600
34.

Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study.

Salazar-Vizcaya L, Wandeler G, Fehr J, Braun D, Cavassini M, Stoeckle M, Bernasconi E, Hoffmann M, Rougemont M, Béguelin C, Rauch A; Swiss HIV Cohort Study .

Open Forum Infect Dis. 2018 Jun 26;5(7):ofy154. doi: 10.1093/ofid/ofy154. eCollection 2018 Jul.

35.

Cost Estimates for Human Immunodeficiency Virus (HIV) Care and Patient Characteristics for Health Resource Use From Linkage of Claims Data With the Swiss HIV Cohort Study.

Leon-Reyes S, Schäfer J, Früh M, Schwenkglenks M, Reich O, Schmidlin K, Staehelin C, Battegay M, Cavassini M, Hasse B, Bernasconi E, Calmy A, Hoffmann M, Schoeni-Affolter F, Zhao H, Bucher HC.

Clin Infect Dis. 2019 Feb 15;68(5):827-833. doi: 10.1093/cid/ciy564.

36.

CD32+ and PD-1+ Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals.

Noto A, Procopio FA, Banga R, Suffiotti M, Corpataux JM, Cavassini M, Riva A, Fenwick C, Gottardo R, Perreau M, Pantaleo G.

J Virol. 2018 Sep 26;92(20). pii: e00901-18. doi: 10.1128/JVI.00901-18. Print 2018 Oct 15.

37.

HIV and Aging - Perhaps Not as Dramatic as We Feared?

Engel T, Raffenberg M, Marzolini C, Cavassini M, Kovari H, Hasse B, Tarr PE.

Gerontology. 2018;64(5):446-456. doi: 10.1159/000489172. Epub 2018 Jun 15. Review.

PMID:
29909411
38.

Missed opportunities for HIV testing among patients newly presenting for HIV care at a Swiss university hospital: a retrospective analysis.

Lhopitallier L, Moulin E, Hugli O, Cavassini M, Darling KEA.

BMJ Open. 2018 Jun 12;8(6):e019806. doi: 10.1136/bmjopen-2017-019806. Erratum in: BMJ Open. 2018 Sep 11;8(9):e019806corr1.

39.

Content analysis of antiretroviral adherence enhancing interview reports.

Kamal S, Nulty P, Bugnon O, Cavassini M, Schneider MP.

Patient Educ Couns. 2018 Sep;101(9):1676-1682. doi: 10.1016/j.pec.2018.05.013. Epub 2018 May 17.

PMID:
29871817
40.

The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis.

Marzel A, Kusejko K, Weber R, Bruggmann P, Rauch A, Roth JA, Bernasconi E, Calmy A, Cavassini M, Hoffmann M, Böni J, Yerly S, Klimkait T, Perreau M, Günthard HF, Kouyos RD; Swiss HIV Cohort Study .

Open Forum Infect Dis. 2018 May 19;5(5):ofy078. doi: 10.1093/ofid/ofy078. eCollection 2018 May.

41.

Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ :  CD8+ ratio.

Hughes RA, May MT, Tilling K, Taylor N, Wittkop L, Reiss P, Gill J, Schommers P, Costagliola D, Guest JL, Lima VD, d'Arminio Monforte A, Smith C, Cavassini M, Saag M, Castilho JL, Sterne JAC.

AIDS. 2018 Jun 19;32(10):1361-1367. doi: 10.1097/QAD.0000000000001848.

42.

Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity.

Kadelka C, Liechti T, Ebner H, Schanz M, Rusert P, Friedrich N, Stiegeler E, Braun DL, Huber M, Scherrer AU, Weber J, Uhr T, Kuster H, Misselwitz B, Cavassini M, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Kouyos RD, Günthard HF, Trkola A; Swiss HIV Cohort Study.

J Exp Med. 2018 Jun 4;215(6):1589-1608. doi: 10.1084/jem.20180246. Epub 2018 May 24.

43.

[Travelers' exposure to HIV and HIV-infected travelers].

Boillat-Blanco N, Cavassini M, Genton B.

Rev Med Suisse. 2018 May 2;14(605):918-921. French.

PMID:
29722497
44.

Single-Cell RNA-Seq Reveals Transcriptional Heterogeneity in Latent and Reactivated HIV-Infected Cells.

Golumbeanu M, Cristinelli S, Rato S, Munoz M, Cavassini M, Beerenwinkel N, Ciuffi A.

Cell Rep. 2018 Apr 24;23(4):942-950. doi: 10.1016/j.celrep.2018.03.102.

45.

Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.

Aebi-Popp K, Wandeler G, Salazar-Vizcaya L, Metzner K, Stöckle M, Cavassini M, Hoffmann M, Lüthi A, Suter F, Bernasconi E, Fehr J, Furrer H, Rauch A; the Swiss HIV Cohort Study.

HIV Med. 2018 Jul;19(6):420-425. doi: 10.1111/hiv.12602. Epub 2018 Mar 24.

PMID:
29573533
46.

Targeted versus non-targeted HIV testing offered via electronic questionnaire in a Swiss emergency department: A randomized controlled study.

Gillet C, Darling KEA, Senn N, Cavassini M, Hugli O.

PLoS One. 2018 Mar 7;13(3):e0190767. doi: 10.1371/journal.pone.0190767. eCollection 2018.

47.

Blood CXCR3+ CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals.

Banga R, Procopio FA, Ruggiero A, Noto A, Ohmiti K, Cavassini M, Corpataux JM, Paxton WA, Pollakis G, Perreau M.

Front Immunol. 2018 Feb 5;9:144. doi: 10.3389/fimmu.2018.00144. eCollection 2018.

48.

Are privacy-enhancing technologies for genomic data ready for the clinic? A survey of medical experts of the Swiss HIV Cohort Study.

Raisaro JL, McLaren PJ, Fellay J, Cavassini M, Klersy C, Hubaux JP; Swiss HIV Cohort Study.

J Biomed Inform. 2018 Mar;79:1-6. doi: 10.1016/j.jbi.2017.12.013. Epub 2018 Jan 10.

49.

Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits.

Perrotta G, Bonnier G, Meskaldji DE, Romascano D, Aydarkhanov R, Daducci A, Simioni S, Cavassini M, Metral M, Lazeyras F, Meuli R, Krueger G, Du Pasquier RA, Granziera C.

Ann Clin Transl Neurol. 2017 Nov 7;4(12):915-920. doi: 10.1002/acn3.493. eCollection 2017 Dec.

50.

Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?

Mocroft A, Laut K, Reiss P, Gatell J, Ormaasen V, Cavassini M, Hadziosmanovic V, Mansinho K, Pradier C, Vasylyev M, Mitsura V, Vandekerckhove L, Ostergaard L, Clarke A, Degen O, Mulcahy F, Castagna A, Sthoeger Z, Flamholc L, Sedláček D, Mozer-Lisewska I, Lundgren JD; EuroSIDA Study.

AIDS. 2018 Jan 14;32(2):205-215. doi: 10.1097/QAD.0000000000001684.

PMID:
29112060

Supplemental Content

Loading ...
Support Center